BioNTech SE (BNTX) Other Non-Current Liabilities (2018 - 2025)

BioNTech SE has reported Other Non-Current Liabilities for 8 years, with the latest figure at $121.3 million in Q4 2025.

• Quarterly Other Non-Current Liabilities rose 29.72% year-over-year to $121.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $121.3 million (up 29.72% YoY) and the FY2025 annual result came in at $117.7 million, up 25.91% from the prior year.
• Other Non-Current Liabilities slipped to $121.3 million in Q4 2025 per BNTX's latest filing, from $247.3 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $803.3 million in Q3 2024 and troughed at $6.8 million in Q1 2021.
• A 5-year average of $332.8 million and a median of $316.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities surged 5535.85% in 2022, then slumped 69.22% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $211.5 million in 2021, then surged by 77.12% to $374.6 million in 2022, then decreased by 22.66% to $289.8 million in 2023, then sank by 67.73% to $93.5 million in 2024, then gained by 29.72% to $121.3 million in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $121.3 million, $247.3 million, and $164.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.